During the past decade, Universitätsfrauenklinik Regensburg conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsfrauenklinik Regensburg" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator, "Belgian Gynaecological Oncology Group" with 1 trials as a collaborator, "Grupo Español de Investigación en Cáncer de Ovario" with 1 trials as a collaborator and "Gynecologic Oncology Trial & Investigation Consortium" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsfrauenklinik Regensburg" are "Ovarian Cancer" (1 trials) and "Recurrent Ovarian Carcinoma" (1 trials). Many other conditions were trialed in "Universitätsfrauenklinik Regensburg" in a lesser frequency.

Most popular intervention types in "Universitätsfrauenklinik Regensburg" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Bevacizumab" (1 trials), "Chemotherapy" (1 trials), "Olaparib" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsfrauenklinik Regensburg" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Universitätsfrauenklinik Regensburg". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitätsfrauenklinik Regensburg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsfrauenklinik Regensburg, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".